NLRP3 and diabetes mellitus: Indeed, NLRP3 inflammasome activation is closely linked to the maintenance of chronic hyperinflammation states characteristic of aging-related diseases, such as atherosclerosis, diabetes mellitus (González-Moro et al., 2022; Zhang et al., 2021) and COPD (Zhang et al., 2021).